Tandem Diabetes Care, Inc.
TNDM
$19.17
$0.995.45%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 102.52% | 29.46% | 13.87% | 65.52% | -89.25% |
| Total Depreciation and Amortization | 5.31% | 4.67% | -3.68% | 19.05% | 10.71% |
| Total Amortization of Deferred Charges | 1.83% | -28.49% | -14.03% | 29.22% | -1.60% |
| Total Other Non-Cash Items | 7.36% | 35.31% | -26.17% | -75.31% | -25.19% |
| Change in Net Operating Assets | -180.43% | 153.05% | 44.35% | 5,671.59% | 53.79% |
| Cash from Operations | 248.52% | 48,589.09% | 16.57% | 56.37% | -223.99% |
| Capital Expenditure | 40.97% | 2.98% | 12.35% | 49.51% | 7.61% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | 100.00% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 170.96% | 66.01% | -77.62% | -101.15% | -127.48% |
| Cash from Investing | 130.21% | 59.00% | -162.13% | 80.80% | -146.35% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -12.04% | -- | -- | -- | -57.10% |
| Repurchase of Common Stock | -- | -145.60% | -- | -5,724.58% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 100.00% | -- | -- | -- |
| Cash from Financing | -12.04% | -136.47% | -176.04% | 2,611.28% | -57.10% |
| Foreign Exchange rate Adjustments | 392.27% | -34.65% | 260.18% | -195.92% | -57.45% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 197.36% | 102.62% | -477.45% | 100.25% | -142.57% |
